Laura Fabbri, MD, says patient wishes should guide care decisions in IPF and lung cancer overlap.
Laura Fabbri, MD
Advertisement
Fabbri, MD, from Imperial College London.
Articles by Laura Fabbri, MD
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on AJMC
1
Newer Agents, New Advantages: Brexpiprazole, Cariprazine, and Lumateperone in MDD
2
Dosing, Tolerability, and Formulary Impact: Aripiprazole and Quetiapine XR in MDD
3
60% of US Women Face Barriers to Postpartum, Mental Health Care
4
Counseling Vitiligo Patients on Time to Repigmentation
5